While the physiological roles of GRβ are not completely understood, increased GRβ expression has been linked to GC resistance in patients suffering from severe asthma [12,13,14,15], leukemia [16], cancer [17], and inflammation [18], which reduces the therapeutic potential of GCs. This evidence concerns the gene GZMB and cancer.